Pharmaceutical Industry Articles & Reports - Page 5

Examine the role of agentic AI in pharmaceutical commercial launches. Learn how autonomous multi-agent systems optimize market access and HCP engagement.

Explore how to structure a Pharma AI Center of Excellence. This guide covers organizational design, hub-and-spoke models, AI governance, and enterprise scaling.

Learn how AI-powered pharma smart factories enable autonomous GMP manufacturing, real-time quality control, and continuous production using digital twins.

Explore SAP S/4HANA implementation in pharmaceutical manufacturing. This guide details GxP compliance, module selection, and computer system validation.

Examine 2026 AI infrastructure investments in pharmaceutical R&D. This report details the Lilly-NVIDIA lab, Earendil funding, and GPU compute deployments.

Examine how pharma organizations deploy private LLMs using air-gapped AI architecture to maintain data sovereignty and comply with FDA and GDPR regulations.

This 2026 guide analyzes GxP compliance software, offering a detailed comparison of eQMS platforms, regulatory standards, and life science quality management.

Examine the 2026 landscape of AI biologics discovery. This analysis details protein modeling, generative design, and key pharma R&D investment trends.

Analyze AI robotics applications in pharma GMP manufacturing. This report details automation use cases across R&D, aseptic fill-finish, packaging, and ROI data.

Read this guide on evaluating digital quality systems (eQMS) for CDMOs. Learn about contract manufacturing software selection, GMP compliance, and integration.

Analyze leading GxP compliance software, eQMS, and document management platforms for life sciences. Learn how systems meet 21 CFR Part 11 and ALCOA+ rules.

Compare ELN, LIMS, and SDMS for pharmaceutical labs. This 2026 guide explains architectural differences, features, compliance, and specific R&D use cases.

Learn how pharma companies build regulatory-grade real-world evidence (RWE) platforms using real-world data for FDA and EMA drug development submissions.

An overview of molecular pathology software, examining LIMS for NGS workflows, multi-omics data integration, and AI analysis tools in precision medicine.

Examine the integration of AI in pharmaceutical CMC submissions and process analytics. Review QbD frameworks, regulatory guidelines, and manufacturing outcomes.

Review NIS2 Directive requirements for the pharma industry. This 2026 cybersecurity compliance checklist covers IT/OT, supply chain, and incident reporting.

Analyze the impact of 2026 U.S. pharma tariffs on global drug supply chains, manufacturing onshoring investments, and digital IT strategy for compliance.

A comprehensive comparison of RTSM software and IRT platforms for clinical trials. Analyze randomization features, trial supply management, and vendor options.

Explore the agentic AI decision framework for the pharmaceutical industry. Learn how to assess build, buy, and partner models for clinical and R&D workflows.

Analyze AI governance in pharmacovigilance signal detection. Review CIOMS XIV and TransCelerate frameworks for risk-based oversight in drug safety monitoring.

Examine how the EU Digital Omnibus impacts pharma AI and medical device compliance. Review AI Act timeline extensions, MDR integration, and GDPR data updates.

Explore a 90-day diagnostic framework for assessing AI readiness in pharma. Learn how to evaluate data governance, regulatory compliance, and integration.

Examine how agentic AI and systems like Microsoft Copilot mitigate the corporate PowerPoint problem in 2026 by automating presentation creation and editing.

Guide to deploying AI in pharmacovigilance under the CIOMS XIV framework. Review core principles for risk-based oversight, model validation, and governance.